|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (right to buy) | $ 8.14 | 12/01/2014 | M | 51,265 (1) | (3) | 01/01/2015 | Common Stock | 51,265 | $ 0 | 0 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
COHEN RON 420 SAW MILL RIVER ROAD ARDSLEY, NY 10502 |
President and CEO |
/s/ Ron Cohen | 12/03/2014 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Exercise and sales pursuant to a 10b5-1 plan. Dr. Cohen exercised 51,265 stock options, all of which were due to expire 1/1/2015 unless exercised. Dr. Cohen sold 19,200 of the resultant shares, the proceeds of which are being used to fund the exercise of the options and the resulting tax liability. In addition, Dr. Cohen vested in 30,384 shares of restricted stock of which he sold 15,194 shares, the proceeds of which are being used to fund the resulting tax liability. A record of all of Dr. Cohen's holdings is available in Acorda's SEC filings. Dr. Cohen retains the majority of the equity he has been granted in the Company since founding Acorda in 1995. |
(2) | The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $35.27 to $36.27 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
(3) | The shares subject to these options vested in installments and were fully vested on 3/01/2009. |